Related Experiment Video
Updated: Jul 9, 2026

In Vitro Model of Coronary Angiogenesis
Published on: March 10, 2020
Developmental coronary maturation is disturbed by aberrant cardiac vascular endothelial growth factor expression and
Nynke M S van den Akker1, Vincenza Caolo, Lambertus J Wisse
1Department of Anatomy and Embryology, Leiden University Medical Center, Einthovenweg 20, PO Box 9600, 2300 RC Leiden, The Netherlands.
Insights
Vascular endothelial growth factor (VEGF) isoforms critically influence coronary artery development by modulating the VEGF/Notch/ephrinB2 pathway. Understanding this balance is key to improving cardiac revascularization therapies.
Area of Science:
- Cardiovascular Biology
- Developmental Biology
- Molecular Signaling
Background:
- Cardiac revascularization therapies often target the vascular endothelial growth factor (VEGF) pathway, but success has been variable.
- The precise role of the VEGF/Notch/ephrinB2 cascade in coronary development requires further elucidation to optimize therapeutic strategies.
Purpose of the Study:
- To investigate the impact of different vascular endothelial growth factor (VEGF) isoforms on coronary development.
- To explore the involvement of the VEGF/Notch/ephrinB2 signaling cascade in normal and abnormal coronary maturation.
- To provide insights for enhancing therapeutic interventions targeting VEGF signaling in cardiac conditions.
Main Methods:
- In vivo studies using Vegf120/120 mouse embryos with immunohistochemistry and RT-qPCR.
- In vitro experiments treating human arterial coronary endothelial cells with VEGF121 or VEGF165, followed by RT-qPCR.
- Analysis of arterial and venous marker expression, including Notch1, Delta-like4, ephrinB2, and chicken ovalbumin upstream promoter transcription factor II.
Main Results:
- Specific VEGF isoforms differentially regulated arterial and venous marker expression in developing coronary endothelium.
- VEGF165 demonstrated the strongest effect on arterial marker expression in vitro.
- Abnormal coronary arteriogenesis and medial development were observed in mouse embryos, with altered expression of smooth muscle alpha-actin, Delta-like1, and Notch3.
Conclusions:
- VEGF isoform-dependent alterations in the VEGF/Notch/ephrinB2 cascade disrupt coronary development.
- This study highlights the importance of spatiotemporal control of VEGF signaling for proper vascular maturation.
- Findings can guide the optimization of VEGF-targeted therapies for cardiac revascularization by balancing angiogenesis and maturation.
Aims:
Currently, many potential cardiac revascularization therapies target the vascular endothelial growth factor (VEGF) pathway, with variable success. Knowledge regarding the role of the VEGF/Notch/ephrinB2 cascade in (ab)normal coronary development will provide information on the subtle balance of VEGF signalling in coronary maturation and might enhance our therapeutic possibilities.
Methods And Results:
The effect of VEGF isoforms on coronary development was explored in vivo using immunohistochemistry and RT-qPCR on Vegf120/120 mouse embryos solely expressing VEGF120. In vitro, human arterial coronary endothelial cells were treated with VEGF121 or VEGF165 upon which RT-qPCR was performed. In vivo, mutant coronary arterial endothelium showed a decrease in protein expression of arterial markers such as cleaved Notch1, Delta-like4, and ephrinB2 concomitant with an increase of venous markers such as chicken ovalbumin upstream promoter transcription factor II. The venous endothelium showed the opposite effect, which was confirmed on the mRNA level. In vitro, mRNA expression of arterial markers highly depended on the VEGF isoform used, with VEGF165 having the strongest effect. Also, coronary arteriogenesis was anomalous in the mouse embryos with decreased arterial and increased venous medial development as shown by staining for smooth muscle alpha-actin, Delta-like1, and Notch3.
Conclusion:
We demonstrate that VEGF isoform-related spatiotemporal cardiac alterations in the VEGF/Notch/ephrinB2 cascade lead to disturbed coronary development. This knowledge can contribute to optimizing therapies targeting VEGF signalling by enabling balancing between angiogenesis and vascular maturation.
More Related Videos
06:51Light-sheet Fluorescence Microscopy to Capture 4-Dimensional Images of the Effects of Modulating Shear Stress on the Developing Zebrafish Heart
Published on: August 10, 2018
05:38Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells
Published on: February 12, 2021
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Regulation of Angiogenesis and Blood Supply
Coronary Artery Disease II: Pathophysiology
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Mechanism of Angiogenesis